検索結果 - Varinder Athwal

  • 検索結果 1 - 7 結果 / 7
結果の絞り込み
  1. 1
    Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications

    Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications 著者: Katherine J. Martin, Anas Hatab, Varinder Athwal, Elliot Jokl, Karen Piper Hanley

    出版事項 2021
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment

    Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment 著者: Eman El‐Khateeb, Adam S. Darwich, Brahim Achour, Varinder Athwal, Amin Rostami‐Hodjegan

    出版事項 2021
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis

    PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis 著者: Katherine J. Martin, James Pritchett, Jessica Llewellyn, Aoibheann F. Mullan, Varinder Athwal, Ross Dobie, Emma Harvey, Leo Zeef, Stuart Farrow, Charles Streuli, Neil C. Henderson, Scott L. Friedman, Neil A. Hanley, Karen Piper Hanley

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy

    The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy 著者: Rosa S. Kim, Daisuke Hasegawa, Nicolas Goossens, Takuma Tsuchida, Varinder Athwal, Xiaochen Sun, Christopher L. Robinson, Dipankar Bhattacharya, Hsin-I Chou, David Y. Zhang, Bryan C. Fuchs, Young Min Lee, Yujin Hoshida, Scott L. Friedman

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis

    SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis 著者: Varinder Athwal, James Pritchett, Katherine J. Martin, Jessica Llewellyn, Jennifer A. Scott, Emma Harvey, Abed M. Zaitoun, Aoibheann F. Mullan, Leo Zeef, Scott L. Friedman, William L. Irving, Neil A. Hanley, Indra Neil Guha, Karen Piper Hanley

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans

    Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans 著者: James Pritchett, Emma Harvey, Varinder Athwal, Andrew Berry, Cliff Rowe, Fiona Oakley, Anna Moles, Derek A. Mann, Nicoletta Bobola, Andrew D Sharrocks, Brian J. Thomson, Abed M. Zaitoun, William L. Irving, Indra Neil Guha, Neil A. Hanley, Karen Piper Hanley

    出版事項 2012
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    <scp>SOX</scp> 9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis

    <scp>SOX</scp> 9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis 著者: Varinder Athwal, James Pritchett, Jessica Llewellyn, Katherine J. Martin, Elizabeth Camacho, Sayyid Raza, Alexander Phythian‐Adams, Lindsay Birchall, Aoibheann F. Mullan, Kim Su, Laurence Pearmain, Grace Dolman, Abed M. Zaitoun, Scott L. Friedman, Andrew S. MacDonald, William L. Irving, Indra Neil Guha, Neil A. Hanley, Karen Piper Hanley

    出版事項 2017
    全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: